1. AB0446 Treatment Effects and Minimal Clinically Important Differences in Patient-Reported Outcomes Following Treatment and Withdrawal of Abatacept, Methotrexate Or Combination Therapy in Patients with Early Rheumatoid Arthritis. (9th June 2015) Authors: Furst, D.E.; Bykerk, V.P.; Burmester, G.R.; Combe, B.G.; Huizinga, T.W.J.; Alemao, E.; Wong, D.A.; Emery, P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1044 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0724 Biomarkers Sensitive to Change in Patients with Systemic Sclerosis – a Systematic Review. (9th June 2015) Authors: Toniolo, M.; Dobrota, R.; Moinzadeh, P.; Ogawa, R.; Furst, D.E.; Denton, C.P.; Khanna, D.; Distler, O. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB1182 Cognitive Debrief of the English Version of the French Flare Assessment in Rheumatoid Arthritis (FLARE) Questionnaire in American English-Speaking RA Patients. (9th June 2015) Authors: Woodworth, T.G.; Barroso, N.; Ranganath, V.K.; Borazan, N.; Guillemin, F.; Fautrel, B.; Furst, D.E. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0059 Routine Assessment of Patient Index Data 3 (RAPID3) – Defined Remission is as Stringent as ACR/Eular Boolean-Defined Remission in a Clinical Trial of Patients with Early Rheumatoid Arthritis Treated with Abatacept. (9th June 2015) Authors: Yazici, Y.; Gandhi, K.K.; Alemao, E.; Furst, D.E. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 440 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0065 Proteomic Profiling Following Immunoaffinity Capture of High-Density Lipoprotein (HDL) Identifies Changes in Multiple HDL-Associated Proteins Following Treatment with Abatacept or Adalimumab in the Ample Study of Patients with Rheumatoid Arthritis. (9th June 2015) Authors: Charles-Schoeman, C.; Gugiu, G.B.; Ge, H.; Shahbazian, A.; Lee, Y.Y.; Wang, X.; Furst, D.E.; Ranganath, V.K.; Maldonado, M.; Reddy, S.T. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0152 On Drug and Drug-Free Remission by Baseline Disease Duration in the Avert Trial: Abatacept Versus Methotrexate Comparison in Patients with Early Rheumatoid Arthritis. (9th June 2015) Authors: Bykerk, V.P.; Burmester, G.R.; Combe, B.G.; Furst, D.E.; Huizinga, T.W.J.; Wong, D.A.; Emery, P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OP0054 Safety and Efficacy of Subcutaneous Tocilizumab in Adults with Systemic Sclerosis: Week 48 Data from the Fasscinate Trial. (9th June 2015) Authors: Khanna, D.; Denton, C.P.; Jahreis, A.; van Laar, J.M.; Cheng, S.; Spotswood, H.; Pope, J.E.; Allanore, Y.; Müller-Ladner, U.; Siegel, J.; Furst, D.E. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OP0056 Macitentan in Patients with Digital Ulcers Associated with Systemic Sclerosis: Results from the Dual-1 and Dual-2 Randomised Controlled Trials. (9th June 2015) Authors: Denton, C.P.; Khanna, D.; Krieg, T.; Le Brun, F.-O.; Merkel, P.A.; Papadakis, K.; Pope, J.; Matucci Cerinic, M.; Furst, D.E. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OP0276 Risk of Serious Adverse Effects Associated with Different Biological and Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomised Trials. (9th June 2015) Authors: Tarp, S.; Furst, D.E.; Luta, G.; Boers, M.; Tarp, U.; Asmussen, K.H.; Bliddal, H.; Brock, B.; Døssing, A.; Jørgensen, T.S.; Thirstrup, S.; Christensen, R. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SAT0164 The First Study of Certolizumab Pegol in Combination with Methotrexate in Dmard-Naïve Early Rheumatoid Arthritis Patients Led to Sustained Clinical Response and Inhibition of Radiographic Progression at 52 Weeks: The C-Early Randomized, Double-Blind, Controlled Phase 3 Study. (9th June 2015) Authors: Emery, P.; Bingham, C.O.; Burmester, G.-R.; Bykerk, V.P.; Furst, D.E.; Mariette, X.; van der Heijde, D.; Tatla, D.; Arendt, C.; Mountian, I.; VanLunen, B.; Weinblatt, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 712 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗